Keyphrases
Therapeutic Potential
100%
Weight Loss
100%
HIV-associated
100%
Risk-benefit Analysis
100%
HIV-related
50%
Lean Body Mass
33%
Common Complications
16%
Tumor Necrosis Factor-α
16%
Poor Prognosis
16%
Combination Therapy
16%
HIV Infection
16%
Potent Inhibitor
16%
Endocrine Disorders
16%
Thalidomide
16%
Opportunistic Infections
16%
Nutritional Intervention
16%
Multifactorial Pathogenesis
16%
Emerging Therapies
16%
Body Weight Gain
16%
Reversible Causes
16%
Recombinant Human Growth Hormone (r-hGH)
16%
Anabolic Therapy
16%
Megestrol
16%
Testosterone Derivatives
16%
Appetite Stimulants
16%
Somatropin
16%
Pharmacology, Toxicology and Pharmaceutical Science
HIV
100%
Human Growth Hormone
33%
Infection
16%
Human Immunodeficiency Virus Infection
16%
Opportunistic Infection
16%
Tumor Necrosis
16%
Testosterone Derivative
16%
Megestrol
16%
Appetite Stimulant
16%
Combination Therapy
16%
Endocrine Disease
16%
Thalidomide
16%